Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Demet Günay"'
Autor:
Refik Erdim, F Helvacioglu, Volkan Sozer, Saide Aytekin, Demet Günay, Serkan Kahraman, Ali Dogan, V Aytekin
Publikováno v:
Bratislava Medical Journal. 119:385-390
OBJECTIVES We aimed to associate a coronary artery disease (CAD) presence and severity with endothelial dysfunction (ED), carotid intima media thickness (CIMT) and Tissue Factor Pathway Inhibitor (TFPI). BACKGROUND ED has a central role in atheroscle
Publikováno v:
Food Chemistry. 230:182-188
In vitro studies were conducted to evaluate the particular nutritional benefits of whole faba bean seed (WFB) and fava bean seed coat (FBSC). Total dietary fiber contents of WFB and FBSC were 27.5% and 82.3%, respectively. FBSC were contained much hi
Autor:
Refik Erdim, Gokce Akan, Fatmahan Atalar, Volkan Sozer, Baris Caynak, Cihan Duran, Demet Günay, Selçuk Görmez
Publikováno v:
Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology. 46
Cytoplasmic fatty acid-binding proteins facilitate the transport of lipids to specific compartments in cells. Fatty acid-binding protein 4 (FABP4), also known as aP2 or A-FABP, plays a key role in the development of atherosclerosis, insulin resistanc
Autor:
Funda Bastug, Demet Günay, Zübeyde Gündüz, Hakan Poyrazoglu, Sibel Yel, Ruhan Düşünsel, Jale Dursun, Sebahat Tulpar, Kenan Yilmaz, Sibel Bolat, Ismail Dursun
Publikováno v:
Renal Failure. 36:562-566
Background: Original peritoneal equilibration test (PET) is an implementation that requires hard work for peritoneal dialysis (PD) staff. Therefore, several authors have attempted to validate short and fast PET protocols, with controversial results.
Autor:
Ahmet Sevim Buyukdevrim, Belhhan Akpinar, Gamze Tanriverdi, Gokce Akan, Zeliha Yazici, Ugur Ozbek, Sema Bilgic-Gazioglu, Fatmahan Atalar, Baris Caynak, Cihan Duran, Demet Günay, Selçuk Görmez
Publikováno v:
Cardiovascular Pathology. 22:183-188
Cardiac visceral fat is accepted to be a new marker for cardiometabolic risk due to its association with increased cardiovascular risk factors. This study aimed to compare the expression of 11 beta hydroxysteroid dehydrogenases (11β-HSD)-1, glucocor
Autor:
Ahmet Sevim Buyukdevrim, Fatmahan Atalar, Selçuk Görmez, Refik Erdim, Ugur Ozbek, Demet Günay, Volkan Sozer, Bellhan Akpinar, Ayse Demirkan, Baris Caynak
Publikováno v:
Internal Medicine. 50:805-810
Objective Metabolic syndrome (MS) is associated with an increased risk of coronary artery disease (CAD) and type 2 diabetes mellitus (DM). In MS, adipose tissue has been shown to function as a paracrine and an endocrine organ secreting various adipoc
Autor:
Belhhan Akpinar, Ugur Ozbek, Ahmet Sevim Buyukdevrim, Ertan Sagbas, Burçak Vural, Demet Günay, Fatmahan Atalar, Cavlan Ciftci, Belgin Susleyici-Duman, Ayse Demirkan
Publikováno v:
Cardiovascular Pathology. 17:392-398
Metabolic syndrome is a cluster of different clinical manifestations that are risk factors for atherothrombotic cardiovascular disorders. Fatty-acid-binding protein 4 (FABP4/aP2), which is highly expressed in adipocytes, specifically exerts intracell
Autor:
Çavlan Türkoğlu, Anastassiia Vertii, Belgin Süsleyici Duman, Penbe Cagatay, Demet Günay, Belhhan Akpinar, A. Sevim Büyükdevrim, Mustafa Güden
Publikováno v:
Annals of Human Biology. 32:620-629
Background: The results of studies that clarify the association of genetic markers at the apolipoprotein B (apo B) gene (EcoRI and XbaI polymorphisms) with coronary artery disease (CAD) are not consistent and suggest that the effect is context depend
Autor:
Belhhan Akpinar, Belgin Süsleyici Duman, A. Sevim Büyükdevrim, Mustafa Güden, Penbe Cagatay, Çavlan Türkoğlu, Demet Günay, Anastassiia Vertii, Esranur Dak
Publikováno v:
Scopus-Elsevier
Context.—Lipoprotein lipase (LPL) plays a central role in lipid metabolism, hydrolyzing triglyceride in chylomicrons and very-low-density lipoproteins. The PvuII polymorphic variant of LPL gene is common and might affect risk of coronary artery dis
Autor:
Remzi Özcan, Demet Günay, Penbe Cagatay, Belgin Süsleyici Duman, A. Sevim Büyükdevrim, Çavlan Türkoğlu
Publikováno v:
Obesity Surgery. 13:699-705
Background: Metabolic syndrome includes abdominal obesity, diabetes type 2, hypertension, dyslipidemia, derangements of fibrinolysis, and atherosclerosis. Since abdominal obesity is one of the major components of the insulin resistance syndrome (IRS)